Efficacies and Chemical Structures of Modern Drugs for Hepatitis C Virus Treatment
- Авторлар: Kazakov A.S.1, Lepakhin V.K.1, Bukatina T.M.1, Snegireva I.I.1, Zatolochina K.É.2
- 
							Мекемелер: 
							- Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
- Peoples Friendship University of Russia
 
- Шығарылым: Том 52, № 6 (2018)
- Беттер: 497-500
- Бөлім: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245278
- DOI: https://doi.org/10.1007/s11094-018-1847-9
- ID: 245278
Дәйексөз келтіру
Аннотация
Hepatitis C virus (HCV) is the leading cause of chronic liver disease, surpassing hepatitis B virus and alcohol. The paradigm for treating HCV has radically changed over the last 20 years. The tolerability and duration of treating HCV patients was altered fundamentally by the emergence of modern and more efficacious treatment regimens and plans. Nevertheless, the risk of developing serious adverse reactions, including those due to drug–drug interactions, remains high. Currently, eight drugs are approved for treating HCV and avoid the use of interferons. The present article reviews these drugs with respect to their efficacy and safety for use in patients with various HCV genotypes.
Негізгі сөздер
Авторлар туралы
A. Kazakov
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
							Хат алмасуға жауапты Автор.
							Email: a.kazakov15@gmail.com
				                					                																			                												                	Ресей, 							8/2 Petrovskii Blvd, Moscow, 127051						
V. Lepakhin
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: a.kazakov15@gmail.com
				                					                																			                												                	Ресей, 							8/2 Petrovskii Blvd, Moscow, 127051						
T. Bukatina
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: a.kazakov15@gmail.com
				                					                																			                												                	Ресей, 							8/2 Petrovskii Blvd, Moscow, 127051						
I. Snegireva
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
														Email: a.kazakov15@gmail.com
				                					                																			                												                	Ресей, 							8/2 Petrovskii Blvd, Moscow, 127051						
K. Zatolochina
Peoples Friendship University of Russia
														Email: a.kazakov15@gmail.com
				                					                																			                												                	Ресей, 							Moscow, 117198						
Қосымша файлдар
 
				
			 
						 
						 
						 
					 
						 
									 
  
  
  
  
  Мақаланы E-mail арқылы жіберу
			Мақаланы E-mail арқылы жіберу  Ашық рұқсат
		                                Ашық рұқсат Рұқсат берілді
						Рұқсат берілді Тек жазылушылар үшін
		                                		                                        Тек жазылушылар үшін
		                                					